Our website will soon be relaunched with a fresh look and improved user experience. Take a look by visiting our test site.
Call us 24/7 at (888) 552-6760
Cancer Treatment Centers of America

Cancer Treatment Centers of America

At Cancer Treatment Centers of America® (CTCA) in Philadelphia, our dedicated team of cancer experts work together under one roof, sharing their knowledge and experience, coordinating treatments and, ultimately, providing comprehensive cancer treatment tailored specifically for you and your cancer.


CTCA Philadelphia
1331 East Wyoming Ave.
Philadelphia, Pennsylvania 19124
New Patients: 888-552-6760
Existing Patients: (215) 607-CTCA

Patient Satisfaction

Overall hospital rating
Physician/surgeon satisfaction
Likelihood of recommending services

(Mean score based on a 0-100 scale)

Why we are different

At CTCA® in Philadelphia, you are surrounded by a team of doctors focused only on treating cancer, which allows you to explore cutting-edge options with a comprehensive, personalized approach. Because our experts only treat cancer, they have an expertise that comes from working with cancer patients every day. Our world-class hospital offers advanced treatments and diagnostic tools and cutting-edge technologies, all in one location. Each patient is assigned a multidisciplinary team of experts dedicated to treating his or her cancer while also helping to manage side effects and maintain quality of life.

As a patient at our Philadelphia hospital, your care team will be led by a medical oncologist, who will design and deliver a treatment plan tailored to your needs and goals. Your care team will include clinicians who commit their time to answering your questions and walking with you through your cancer journey—from your first visit to your diagnostic tests, treatment visits and follow-up appointments. Your personalized care plan may also include evidence-informed supportive therapies, delivered by registered dietitians, naturopathic oncology providers, mind-body therapists, massage therapists and others, to help you manage cancer-related side effects and maintain the strength you need to continue treatment and get back to living your life.

Our Breast and Lung Cancer Center

Teams of experts under one roof, focused on individual cancer types

Breast Cancer Center
Lung Cancer Center

The CTCA Lung Cancer Center in Philadelphia  and the CTCA Breast Cancer Center in Philadelphia  reflect our commitment to delivering state-of-the-art treatment options to patients fighting these complex diseases. By focusing on one cancer type, the teams of experts at our Lung Cancer Center and Breast Cancer Center are better able to stay up-to-date on emerging treatments and technologies and help you make more informed decisions about your care. We also offer genomic tumor assessments to qualified patients, if we believe the tests may help identify treatment options not previously considered. Your oncologist will help determine if you are a candidate for genomic testing.

At the CTCA Breast Cancer Center in Philadelphia, our doctors have training and experience in treating a wide range of breast cancer types and subtypes, from triple-negative and HER2-positive cancers to metastatic disease and rare cases like male breast cancer and Paget’s disease of the breast. Depending on your cancer type, stage and other factors, your treatment plan may include surgical procedures, including oncoplastic reconstruction options to help you restore your breasts to a natural shape. If your care plan includes chemotherapy, hormone therapy, radiation therapy or targeted therapy, the Breast Cancer Center team may recommend various state-of-the-art technologies to personalize your treatment regimen. 

Because lung cancer often is diagnosed in the advanced stages, it is important to turn to clinical experts with training and expertise in treating lung cancer specifically. At the CTCA Lung Cancer Center, our singular focus helps our oncologists stay up to date on new treatments and technologies. As part of our commitment to providing state-of-the-art lung cancer treatment options, we offer qualifying patients an opportunity to participate in clinical trials in immunotherapy, and other areas of innovation. Our Lung Cancer Center team will help determine whether you are a candidate for a study and, if so, help you enroll.

Our cancer experts also recognize that patients often experience side effects, including appetite loss, nausea, pain and fatigue. To help address cancer-related side effects, your team may include supportive care experts in nutrition therapy, pain management, spiritual support and other services, collaborating to design a treatment plan tailored to your needs.

High-Risk Program at CTCA in Philadelphia

Inherited gene defects have been linked to up to 10 percent of all cancer diagnoses, according to the National Cancer Institute. The High-Risk Program at CTCA is designed to educate patients about the risks associated with gene mutations and provide screening and structured surveillance for women and men who are at increased risk for cancer based on hereditary factors.

Researchers have identified dozens of hereditary gene mutations that may be responsible for a variety of cancers.

The cancer experts at CTCA have developed a program designed to help patients reduce their risk of cancer or to help find cancer at early stages when possible.

Learn more about the High-Risk Program at CTCA in Philadelphia

Meet our
Genetic Counselor


Melanie Corbman, a licensed, certified Genetic Counselor, leads the High-Risk Program at CTCA in Philadelphia. Corbman is a member of the National Society of Genetic Counselors and works with the national support group FORCE (Facing Our Risk of Cancer Empowered) for individuals with hereditary risks for breast and ovarian cancer.

Learn more

Clinical experts

At CTCA in Philadelphia, our Department of Surgical Oncology, led by Chief of Surgery and Director of Gynecologic Oncology and Robotic Surgery Dr. Justin Chura, provides a variety of surgical techniques to treat lung, breast, pancreatic and many other cancers.

Our surgeons are also trained in reconstructive microsurgery and oncoplastic surgical procedures designed to help rebuild parts of the body affected by cancer.

Our gynecologic oncology team offers state-of-the-art treatments for women with cancer of the reproductive system, including ovarian, cervical, uterine, vaginal and vulvar cancers.

Your cancer care team will be led by a medical oncologist and, depending on your needs, your team may also include a surgical oncologist, radiation oncologist, pathologist, interventional pulmonologist, hematologist oncologist and other cancer experts.

View all medical departments at CTCA in Philadelphia

Clinician spotlight


Dr. Pamela Crilley, Chair of the Department of Medical Oncology at Cancer Treatment Center of America® (CTCA), is board certified in medical oncology and internal medicine. Dr. Crilley has treated cancer patients for more than 25 years. Her research and clinical papers have been published extensively, and she has been publicly recognized for her excellence in clinical care.

Learn more about Dr. Crilley

View all doctors and clinicians at CTCA in Philadelphia

State-of-the-art treatments

With so many cancer treatment options available, our patients face many decisions regarding their care. At CTCA in Philadelphia, you'll find innovative treatments and technologies—all under one roof. Our cancer experts use sophisticated diagnostic tools and state-of-the-art equipment and techniques to treat all types of cancer.

Patients who meet certain criteria may benefit from advanced genomic testing, which is used to help identify specific mutations in a tumor and match them to treatments that may not have otherwise been considered.

Depending on your cancer type and other factors, our medical oncologists may recommend immunotherapy drugs, which are designed to trigger the immune system to fight cancer.

At our hospital in Philadelphia, our patients are also participating in a number of clinical trials, including the American Society of Clinical Oncology’s TAPUR study, which aims to improve our understanding of how commercially available anti-cancer drugs perform on a broader range of cancers, by matching the drugs to tumors with specific genomic mutations that the drugs are designed to target.

View all treatment options available at CTCA in Philadelphia

Genetic testing

breast center genetic testing

At CTCA, the experts in our Department of Genetics offer education, counseling and testing to qualified patients, to determine whether their cancer was caused by an inherited gene mutation. This information may inform us as to whether the patient is at an increased risk of developing a second cancer. Our program also offers options to reduce the risk of other cancers, when clinically appropriate.

Learn more about genetic testing at CTCA in Philadelphia

Patient-centered approach

At CTCA, our focus on patient-centered care puts you and your needs at the forefront of your treatment, so you and your family can focus on healing.

Each patient has a team of cancer experts assigned to his or her care—some devoted to treating the cancer, others focused on combating side effects.

Our doctors and clinicians work together to deliver comprehensive and personalized cancer care tailored specifically to your needs. Your doctors and clinicians will work with you and one another to design a plan, monitor your progress and make adjustments when necessary.

Learn more about integrative care

Integrative Care

Integrative Cancer Care

To help prevent treatment delays or interruptions, your care team may suggest a number of evidence-informed supportive therapies to help you manage side effects, boost your immune system and maintain your strength throughout treatment.

Watch our video to learn more about managing cancer-related side effects


joint commissionCTCA in Philadelphia is accredited by The Joint Commission with Full Standards Compliance. This accreditation is awarded to a health care organization that demonstrates satisfactory compliance with applicable standards in all performance areas. Our Philadelphia hospital is also accredited by several other renowned health care organizations, including:

  • College of American Pathologists
  • American College of Radiology
  • American College of Surgeons Commission on Cancer
  • Quality Respiratory Care Institution
  • Outstanding Achievement Award Commission on Cancer
  • Quality Oncology Practice Initiative Certification
  • Foundation for the Accreditation of Cellular Therapy

Learn more about our accreditations

Cancer Types
Our Doctors